Greinwald; Roland

Patent Applications and Registrations

Patent applications and USPTO patent grants for Greinwald; Roland.The latest application filed is for "pellets having a multi-layer structure for delayed release of the active substance in the distal colon".

Company Profile

7.7.9

Greinwald; Roland - Kenzingen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagus Grant 11,382,860 - Greinwald , et al. July 12, 2	2022-07-12
Pellets having a multi-layer structure for delayed release of the active substance in the distal colon Grant 11,173,121 - Wilhelm , et al. November 16, 2	2021-11-16
Optimized high-dose mesalazine-containing tablet Grant 11,135,159 - Wilhelm , et al. October 5, 2	2021-10-05
Pellets Having A Multi-layer Structure For Delayed Release Of The Active Substance In The Distal Colon App 20210228487 - WILHELM; Rudolf ; et al.	2021-07-29
Pharmaceutical Formulation For The Treatment Of Inflammatory Changes To The Rectum App 20210100819 - WILHELM; Rudolph ; et al.	2021-04-08
Pharmaceutical formulation for the treatment of inflammatory changes to the rectum Grant 10,905,699 - Wilhelm , et al. February 2, 2	2021-02-02
Optimized Pharmaceutical Formulation For The Treatment Of Inflammatory Conditions Of The Esophagus App 20200337997 - GREINWALD; Roland ; et al.	2020-10-29
Use of Nor-Ursodeoxycholic Acid for Reducing Liver Fat App 20200246357 - Kind Code	2020-08-06
Optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagus Grant 10,695,291 - Greinwald , et al.	2020-06-30
Optimized Pharmaceutical Formulation For The Treatment Of Inflammatory Conditions Of The Esophagus App 20190358155 - GREINWALD; Roland ; et al.	2019-11-28
Optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagus Grant 10,369,100 - Greinwald , et al.	2019-08-06
Optimised High-dose Mesalazine-containing Tablet App 20180311155 - WILHELM; Rudolph ; et al.	2018-11-01
Pharmaceutical Formulation For The Treatment Of Inflammatory Changes To The Rectum App 20180200268 - WILHELM; Rudolph ; et al.	2018-07-19
Optimized Pharmaceutical Formulation For The Treatment Of Inflammatory Conditions Of The Esophagus App 20180185277 - Greinwald; Roland ; et al.	2018-07-05
Optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagus Grant 9,867,780 - Greinwald , et al. January 16, 2	2018-01-16
Optimized Pharmaceutical Formulation For The Treatment Of Inflammatory Conditions Of The Esophagus App 20160324772 - GREINWALD; Roland ; et al.	2016-11-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.